• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2 型糖尿病外周动脉疾病:厄瓜多尔初级保健人群的生存分析。

Peripheral Artery Disease in Type 2 Diabetes Mellitus: Survival Analysis of an Ecuadorian Population in Primary Care.

机构信息

Pontifical Catholic University of Ecuador, Pichincha, Quito, Ecuador.

State University of Southern Manabí, Jipijapa, Manabí, Ecuador.

出版信息

J Prim Care Community Health. 2020 Jan-Dec;11:2150132720957449. doi: 10.1177/2150132720957449.

DOI:10.1177/2150132720957449
PMID:33016190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7543104/
Abstract

BACKGROUND

Peripheral artery disease (PAD) is associated with cardiovascular risk in type 2 diabetes mellitus (DM). The ankle-brachial index (ABI) is used for diagnosis of PAD.

OBJECTIVES

Establish the prevalence and incidence rate for PAD and determine the associated factors and survival time for the development of PAD.

METHODS

Retrospective cross-sectional cohort study (follow up: 10 years) in 578 DM patients with at least 1 ABI measurement in a primary level of care diabetes clinic. Data was collected from clinical records. Sociodemographic and laboratory variables were analyzed determining its association (mean difference and bivariate logistic regression). Survival was calculated through life tables and Kaplan-Meier analysis.

RESULTS

The prevalence of PAD was 13.98%. The incidence rate through the time of follow up was 23.38 per 1000 person-year (95% CI: 19.91-27.26). The group that developed PAD showed higher glycated hemoglobin levels ( = .025), more years of DM ( < .001) and lower glomerular filtration rate (GFR,  = .003). The median time for developing PAD was 26.97 years (95% CI: 26.89-27.05). The risk for PAD was higher in females (95% CI: 1.51-4.38), GFR <60 mL/min/m (95% CI: 1.05-2.22) and use of metformin plus insulin (95% CI: 1.10-2.35).

CONCLUSION

Half of a DM patient's population in primary level of care will develop PAD in the third decade of disease. There are identifiable risk factors for PAD development in DM in the primary level of care such as low GFR, female sex, and use of metformin plus insulin.

摘要

背景

外周动脉疾病(PAD)与 2 型糖尿病(DM)患者的心血管风险相关。踝肱指数(ABI)用于诊断 PAD。

目的

确定 PAD 的患病率和发生率,并确定 PAD 发展的相关因素和生存时间。

方法

这是一项回顾性的横断面队列研究(随访时间:10 年),纳入了在初级保健糖尿病诊所至少进行过一次 ABI 测量的 578 例 DM 患者。数据来自临床记录。分析社会人口学和实验室变量,确定其相关性(均数差和双变量逻辑回归)。通过寿命表和 Kaplan-Meier 分析计算生存情况。

结果

PAD 的患病率为 13.98%。在随访期间,发病率为 23.38/1000 人年(95%CI:19.91-27.26)。发生 PAD 的组糖化血红蛋白水平更高(=0.025),DM 病程更长( < 0.001),肾小球滤过率(GFR)更低(=0.003)。发生 PAD 的中位时间为 26.97 年(95%CI:26.89-27.05)。女性发生 PAD 的风险更高(95%CI:1.51-4.38),GFR <60 mL/min/m(95%CI:1.05-2.22)和使用二甲双胍加胰岛素(95%CI:1.10-2.35)。

结论

在初级保健水平,一半的 DM 患者将在疾病的第三个十年发生 PAD。在初级保健中,DM 患者发生 PAD 的可识别风险因素包括低 GFR、女性、使用二甲双胍加胰岛素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec90/7543104/9c478f5917f2/10.1177_2150132720957449-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec90/7543104/4ff9870fb83c/10.1177_2150132720957449-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec90/7543104/9c478f5917f2/10.1177_2150132720957449-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec90/7543104/4ff9870fb83c/10.1177_2150132720957449-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec90/7543104/9c478f5917f2/10.1177_2150132720957449-fig2.jpg

相似文献

1
Peripheral Artery Disease in Type 2 Diabetes Mellitus: Survival Analysis of an Ecuadorian Population in Primary Care.2 型糖尿病外周动脉疾病:厄瓜多尔初级保健人群的生存分析。
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720957449. doi: 10.1177/2150132720957449.
2
Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors.2型糖尿病患者外周动脉疾病的患病率及其与冠状动脉疾病及其危险因素的相关性。
J Assoc Physicians India. 2012 Jul;60:28-32.
3
[Prevalence and factors associated with peripheral artery disease in patients with type 2 diabetes mellitus in Primary Care].[基层医疗中2型糖尿病患者外周动脉疾病的患病率及相关因素]
Semergen. 2015 May-Jun;41(4):183-90. doi: 10.1016/j.semerg.2014.05.004. Epub 2014 Jul 17.
4
Limb and cardiovascular event risk in type 1 and 2 diabetic patients with peripheral artery disease.1 型和 2 型糖尿病合并外周动脉疾病患者的肢体和心血管事件风险。
Vasa. 2023 Sep;52(5):310-316. doi: 10.1024/0301-1526/a001086. Epub 2023 Jul 31.
5
The ankle-brachial index for assessing the prevalence of peripheral artery disease and cardiovascular risk in patients with type 2 diabetes mellitus.踝臂指数评估 2 型糖尿病患者外周动脉疾病和心血管风险的患病率。
Nutr Metab Cardiovasc Dis. 2023 Mar;33(3):560-567. doi: 10.1016/j.numecd.2022.11.019. Epub 2022 Nov 19.
6
Peripheral arterial disease and its correlates in patients with type 2 diabetes mellitus in a teaching hospital in northern Nigeria: a cross-sectional study.尼日利亚北部一所教学医院中 2 型糖尿病患者的外周动脉疾病及其相关因素:一项横断面研究。
BMC Cardiovasc Disord. 2020 Feb 28;20(1):102. doi: 10.1186/s12872-020-01395-3.
7
Associations of diabetes mellitus and other cardiovascular disease risk factors with decline in the ankle-brachial index.糖尿病及其他心血管疾病危险因素与踝臂指数下降的关联。
Vasc Med. 2014 Dec;19(6):465-72. doi: 10.1177/1358863X14554033. Epub 2014 Oct 30.
8
Prevalence and predictors of peripheral arterial disease determined by ankle brachial index in diabetes population treated within primary care services in a non-urban area of lower northern Thailand.在泰国北部低地的一个非城市地区,通过踝臂指数在初级保健服务中确定的糖尿病患者外周动脉疾病的患病率和预测因素。
Diab Vasc Dis Res. 2020 Nov-Dec;17(6):1479164120966997. doi: 10.1177/1479164120966997.
9
Prevalence, clinical profile, and risk factors of peripheral artery disease in an Iraqi cohort of chronic kidney disease.在伊拉克慢性肾脏病队列中,外周动脉疾病的患病率、临床特征和危险因素。
Medicine (Baltimore). 2023 Oct 27;102(43):e35577. doi: 10.1097/MD.0000000000035577.
10
[Comparison of two coronary risk equivalents: diabetes mellitus and peripheral arterial disease].两种冠心病风险等同因素的比较:糖尿病与外周动脉疾病
Dtsch Med Wochenschr. 2008 Nov;133(45):2317-22. doi: 10.1055/s-0028-1100921. Epub 2008 Oct 28.

引用本文的文献

1
Exploratory Study on the Prevalence of Peripheral Artery Disease in Asymptomatic Patients With Diabetes and Hypertension in a Family Health Unit.某家庭健康机构中糖尿病和高血压无症状患者外周动脉疾病患病率的探索性研究
Cureus. 2025 Jul 2;17(7):e87185. doi: 10.7759/cureus.87185. eCollection 2025 Jul.
2
The incidence and predictors of peripheral arterial disease among type 2 diabetes mellitus patients at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia, 2023: A retrospective follow-up study.2023年埃塞俄比亚西北部费莱格·希沃特综合专科医院2型糖尿病患者外周动脉疾病的发病率及预测因素:一项回顾性随访研究
PLoS One. 2025 Apr 1;20(4):e0320948. doi: 10.1371/journal.pone.0320948. eCollection 2025.
3

本文引用的文献

1
Variants Associated with the Ankle Brachial Index Differ by Hispanic/Latino Ethnic Group: a genome-wide association study in the Hispanic Community Health Study/Study of Latinos.与踝臂指数相关的变异体因西班牙裔/拉丁裔族群而异:西班牙裔社区健康研究/拉丁裔研究中的全基因组关联研究。
Sci Rep. 2019 Aug 6;9(1):11410. doi: 10.1038/s41598-019-47928-5.
2
Which Factors may reduce the Health-Related Quality of Life of Ecuadorian Patients with Diabetes?哪些因素可能会降低厄瓜多尔糖尿病患者与健康相关的生活质量?
P R Health Sci J. 2019 Jun;38(2):102-108.
3
Decline in ankle-brachial index is stronger in poorly than in well controlled diabetes: Results from the Heinz Nixdorf Recall cohort study.
A portable optical pulsatile flowmetry demonstrates strong clinical relevance for diabetic foot perfusion assessment.
一种便携式光学搏动血流测量法对糖尿病足灌注评估具有很强的临床相关性。
APL Bioeng. 2024 Feb 21;8(1):016109. doi: 10.1063/5.0182670. eCollection 2024 Mar.
4
Mortality Risk Assessment in Peripheral Arterial Disease-The Burden of Cardiovascular Risk Factors over the Years: A Single Center's Experience.外周动脉疾病的死亡风险评估——多年来心血管危险因素的负担:单中心经验
Diagnostics (Basel). 2022 Oct 15;12(10):2499. doi: 10.3390/diagnostics12102499.
踝臂指数下降在控制不佳的糖尿病中比控制良好的糖尿病中更为明显:海因茨·尼克斯多夫回顾性队列研究的结果。
Atherosclerosis. 2019 May;284:37-43. doi: 10.1016/j.atherosclerosis.2019.02.021. Epub 2019 Mar 3.
4
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).2017年欧洲心脏病学会(ESC)与欧洲血管外科学会(ESVS)合作制定的外周动脉疾病诊断和治疗指南:涵盖颅外颈动脉和椎动脉、肠系膜、肾、上肢和下肢动脉粥样硬化疾病的文件 认可机构:欧洲卒中组织(ESO) 欧洲心脏病学会(ESC)和欧洲血管外科学会(ESVS)外周动脉疾病诊断和治疗特别工作组
Eur Heart J. 2018 Mar 1;39(9):763-816. doi: 10.1093/eurheartj/ehx095.
5
Prevalence and risk factors associated with peripheral arterial disease in an adult population from Colombia.哥伦比亚成年人群外周动脉疾病的患病率及相关危险因素
Arch Cardiol Mex. 2018 Apr-Jun;88(2):107-115. doi: 10.1016/j.acmx.2017.02.002. Epub 2017 Jun 13.
6
Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes.心血管疾病生物标志物与2型糖尿病患者肾功能下降有关。
Diabetologia. 2017 Aug;60(8):1400-1408. doi: 10.1007/s00125-017-4297-0. Epub 2017 May 20.
7
Statin Therapy Reduces Future Risk of Lower-Limb Amputation in Patients With Diabetes and Peripheral Artery Disease.他汀类药物治疗可降低糖尿病合并外周动脉疾病患者下肢截肢的未来风险。
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2373-2381. doi: 10.1210/jc.2016-3717.
8
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2016 年美国心脏协会/美国心脏病学会下肢外周动脉疾病管理指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南工作组的报告。
Circulation. 2017 Mar 21;135(12):e686-e725. doi: 10.1161/CIR.0000000000000470. Epub 2016 Nov 13.
9
Vascular Complications of Diabetes.糖尿病血管并发症。
Circ Res. 2016 May 27;118(11):1771-85. doi: 10.1161/CIRCRESAHA.115.306884.
10
Peripheral Arterial Disease Incidence and Associated Risk Factors in a Mediterranean Population-based Cohort. The REGICOR Study.地中海人群队列中周围动脉疾病的发病率及相关危险因素。REGICOR研究。
Eur J Vasc Endovasc Surg. 2016 May;51(5):696-705. doi: 10.1016/j.ejvs.2015.12.045. Epub 2016 Feb 20.